Koji Izutsu

53PUBLICATIONS
262CO-AUTHORS
Dental therapeutics, pharmacology and toxicologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Aug 17, 2026
Safety and Effectiveness of Denileukin Diftitox-cxdl in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma: An All-Case Post-Marketing Study in Japan.

|Jul 24, 2026
Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients.

|Jun 09, 2026
TFH phenotype and response to tucidinostat in relapsed/refractory PTCL: analysis of patients from a phase IIb trial.

|Apr 27, 2026
Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.

|Apr 22, 2026
Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.

|Apr 16, 2026
Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial.

Pageof 9

Frequent Collaborators

6 joint publications

Koji Kato

6 joint publications

Suguru Fukuhara

6 joint publications

Shinichi Makita

5 joint publications

Franck Morschhauser